Health & Wellness

Cannabis Use Linked to Rising Childhood Leukemia Rates: “Legalization” Faulted by Study

mm
Published
Add MyCannabis.com to your preferred sources on Google

Childhood cancer, particularly Acute Lymphoid Leukemia (ALL), has been a growing concern worldwide. In the United States, ALL rates have surged significantly over the past few decades, with unclear reasons behind this increase. Recent research has pointed towards a potential link between prenatal cannabis exposure and elevated rates of childhood leukemia. This article highlights a study that was conducted by researchers from the University of Western Australia and published in BMC Cancer in September 2021. 

Understanding the Data

The study examined national data from various sources, including the Surveillance Epidemiology and End Results database and the National Survey of Drug Use and Health, to investigate the relationship between cannabis use and childhood leukemia rates. Robust statistical analyses revealed a dose-response relationship between ALL incidence and cannabis exposure, with cannabis showing the strongest effect compared to other substances like alcohol and cocaine. Moreover, the study identified specific cannabinoids, such as THC and cannabigerol, as significant contributors to the observed association.

Implications of Findings

The findings underscore the significant role of cannabis in contributing to the rise in childhood leukemia rates. Furthermore, the study highlights the exacerbating effects of cannabis legalization, with states that have relaxed legal paradigms exhibiting higher ALL incidence rates. The data also shed light on the disproportionate impact of cannabis on ethnic minorities, contributing to existing differentials in ALL rates.

Conclusion

The evidence presented in this study strongly suggests a causal relationship between cannabis use and childhood leukemia, particularly ALL. The findings underscore the urgent need for public health interventions to address the growing prevalence of cannabis use, especially among pregnant women and adolescents. Furthermore, the widespread legalization of cannabis poses additional challenges, exacerbating the already alarming rates of childhood leukemia. Efforts to mitigate the impact of cannabis on childhood health should be prioritized, with a focus on education, regulation, and targeted interventions aimed at reducing cannabis consumption and its adverse effects on vulnerable populations.

Reference

Reece, A.S., Hulse, G.K. Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study. BMC Cancer 21, 984 (2021). https://doi.org/10.1186/s12885-021-08598-7

mm

Lydia K. (Bsc. RN) is a cannabis writer, which, considering where you’re reading this, makes perfect sense. Currently, she is a regular writer for Mace Media. In the past, she has written for MyBud, RX Leaf & Dine Magazine (Canada), CBDShopy (UK) and Cannavalate & Pharmadiol (Australia). She is best known for writing epic news articles and medical pieces. Occasionally, she deviates from news and science and creates humorous articles. And boy doesn't she love that! She equally enjoys ice cream, as should all right-thinking people.